Monte Rosa Therapeutics, Inc.
GLUE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826457
In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Monte Rosa Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 52 | 1 | 57 | +6 |
| Shares | 39.9M | 2.83K | 38.8M | −1.16M (−2.9%) |
| Value | $559.9M | $40.0K | $375.0M | −$184.8M (−33.0%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Oconnor LLC | 101,647 | $983.0K | 0.01% |
| Sarasin & Partners LLP | 65,081 | $629.0K | 0.01% |
| Susquehanna International Group, LLP | 26,414 | $255.0K | 0.00% |
| Millennium Management LLC | 17,403 | $168.0K | 0.00% |
| DekaBank Deutsche Girozentrale | 16,500 | $162.0K | 0.00% |
| Squarepoint Ops LLC | 15,302 | $148.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 15,130 | $146.0K | 0.00% |
| State of Wisconsin Investment Board | 14,087 | $136.0K | 0.00% |
| SG Americas Securities, LLC | 11,319 | $109.0K | 0.00% |
| Voya Investment Management LLC | 10,430 | $101.0K | 0.00% |
| Credit Suisse AG | 10,077 | $98.0K | 0.00% |
| Nisa Investment Advisors, LLC | 2,000 | $19.0K | 0.00% |
Sold out (6)
Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Alliancebernstein L.P. | 81,302 | $1.14M |
| UBS Group AG | 29,408 | $412.0K |
| Laurion Capital Management LP | 23,252 | $326.0K |
| Allspring Global Investments Holdings, LLC | 13,899 | $194.0K |
| ProShare Advisors LLC | 10,230 | $144.0K |
| STRS Ohio | 6,800 | $95.0K |
Not filed for Q2 2022 yet (1)
Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 2,832 | $40.0K |